Carregant...

Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study

Targeting androgen receptor (AR) axis signaling by disrupting androgen-AR interactions remains the primary treatment for metastatic prostate cancer. Unfortunately, all men develop resistance to primary castrating therapy and secondary androgen deprivation therapies (ADTs). Resistance develops in par...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Transl Med
Autors principals: Schweizer, Michael T., Antonarakis, Emmanuel S., Wang, Hao, Ajiboye, A. Seun, Spitz, Avery, Cao, Haiyi, Luo, Jun, Haffner, Michael C., Yegnasubramanian, Srinivasan, Carducci, Michael A., Eisenberger, Mario A., Isaacs, John T., Denmeade, Samuel R.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4507510/
https://ncbi.nlm.nih.gov/pubmed/25568070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3010563
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!